Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEX
1876
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $646K | ﹤0.01% |
81,219
+46,800
| +136% | +$419K |
|
1877
Sphere Entertainment
SPHR
$6.29B
| $641K | ﹤0.01% |
10,866
+5,898
| +119% | +$319K |
|
1878
Northwest Bancshares
NWBI
$2.3B
| $640K | ﹤0.01% |
53,307
+28,800
| +118% | +$391K |
|
|
INFN
1879
DELISTED
Infinera Corporation Common Stock
INFN
| $639K | ﹤0.01% |
82,379
+47,511
| +136% | +$345K |
|
1880
Remitly
RELY
$5.1B
| $634K | ﹤0.01% |
37,375
+20,154
| +117% | +$274K |
|
1881
Dave & Buster's
PLAY
$361M
| $633K | ﹤0.01% |
17,206
+9,433
| +121% | +$376K |
|
1882
Compass Diversified
CODI
$908M
| $632K | ﹤0.01% |
33,147
+20,953
| +172% | +$429K |
|
1883
Arrow Electronics
ARW
$10.7B
| $631K | ﹤0.01% |
5,057
-31
| -0.6% | -$3.68K |
|
1884
Trustmark
TRMK
$2.79B
| $628K | ﹤0.01% |
25,458
+13,906
| +120% | +$411K |
|
1885
PubMatic
PUBM
$783M
| $625K | ﹤0.01% |
45,267
+21,283
| +89% | +$307K |
|
1886
Kinross Gold
KGC
$32.6B
| $625K | ﹤0.01% |
133,216
| – | – |
|
|
AVNS
1887
DELISTED
Avanos Medical
AVNS
| $625K | ﹤0.01% |
21,003
+11,267
| +116% | +$327K |
|
1888
Virtus Investment Partners
VRTS
$1.12B
| $624K | ﹤0.01% |
3,279
+1,086
| +50% | +$220K |
|
|
IXAQ
1889
DELISTED
IX Acquisition Corp. Class A Ordinary Share
IXAQ
| $622K | ﹤0.01% |
60,415
| – | – |
|
1890
Dutch Bros
BROS
$8.91B
| $621K | ﹤0.01% |
+19,623
| New | +$664K |
|
|
TGVC
1891
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
| $619K | ﹤0.01% |
59,676
| – | – |
|
1892
La-Z-Boy
LZB
$1.64B
| $619K | ﹤0.01% |
+21,284
| New | +$605K |
|
1893
Relay Therapeutics
RLAY
$4.4B
| $617K | ﹤0.01% |
37,420
+19,090
| +104% | +$342K |
|
|
LAZR
1894
DELISTED
Luminar Technologies
LAZR
| $617K | ﹤0.01% |
6,348
+3,339
| +111% | +$350K |
|
1895
City Holding Co
CHCO
$2.07B
| $616K | ﹤0.01% |
6,790
+3,604
| +113% | +$341K |
|
|
GTY
1896
Getty Realty Corp
GTY
$2.04B
| $615K | ﹤0.01% |
17,086
+9,512
| +126% | +$333K |
|
1897
Celldex Therapeutics
CLDX
$3.52B
| $614K | ﹤0.01% |
17,045
+8,961
| +111% | +$387K |
|
1898
TotalEnergies
TTE
$194B
| $613K | ﹤0.01% |
+10,389
| New | +$639K |
|
1899
3D Systems Corp
DDD
$603M
| $608K | ﹤0.01% |
56,775
+31,546
| +125% | +$322K |
|
|
ALEX
1900
DELISTED
Alexander & Baldwin
ALEX
| $608K | ﹤0.01% |
32,150
+17,448
| +119% | +$331K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.